FIELD: pulmonology; allergology; internal medicine.
SUBSTANCE: used for differential diagnosis of bronchial asthma phenotypes. Blood levels of periostin and procalcitonin are determined. The periostin to procalcitonin ratio index is calculated. When its values are below 3.8, non-allergic bronchial asthma is diagnosed. At values above 3.8, allergic bronchial asthma is diagnosed.
EFFECT: method provides a simpler, more economical and accurate differential diagnosis of bronchial asthma phenotypes by assessing the activity of markers of allergic and infectious inflammation.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR RAPID DIAGNOSIS OF THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2789426C1 |
| METHOD FOR DIAGNOSING ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA | 2021 |
|
RU2759772C1 |
| METHOD FOR DIAGNOSING SYSTEMIC INFLAMMATORY RESPONSE OF ORGANISM FROM MAIN BLOOD PLASMA EOSINOPHIL CATIONIC PROTEIN | 2005 |
|
RU2312357C2 |
| METHOD FOR DIAGNOSING ALLERGIC BRONCHIAL ASTHMA | 2021 |
|
RU2780687C1 |
| METHOD FOR SELECTING TARGETED THERAPY IN CHRONIC T2-INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINUSES | 2023 |
|
RU2824263C1 |
| METHOD FOR DIAGNOSING BRONCHIAL ASTHMA IN PATIENT BY DETERMINING CONCENTRATION OF ARGINASE-1 IN BLOOD PLASMA | 2024 |
|
RU2825347C1 |
| METHOD FOR DETERMINING SEVERITY OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2021 |
|
RU2767892C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA | 2011 |
|
RU2469332C1 |
| METHOD FOR DIAGNOSING SEVERE CASES OF BRONCHIAL ASTHMA | 1995 |
|
RU2120635C1 |
| METHODS FOR DIAGNOSING AND TREATING RELATED TO TH2 INHIBITION | 2011 |
|
RU2578468C2 |
